entertainment -WSS

entertainment

author：comprehensive 2025-09-07 04:07:34 - browse：172

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Naloxone nonprofit donates 200,000 doses after FDA approval

hotspot

focus

WSS

NIH trials fail to test meaningful long Covid therapies, experts say

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

FDA panel endorses Alnylam’s heart drug — after picking it apart

Acelyrin, a rare IPO success, stumbles in its first big test

Food makers tried to stack nutrition panel with preferred experts

explore

entertainment

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Bright Health sells Medicare Advantage business to Molina

How housing is health care on Long Island

Medical leaders decry Supreme Court decision on affirmative action

Food makers to regulators: Ultra

ChatGPT in medicine: STAT answers readers' burning questions

Anavex keeps shifting the goalposts in its clinical trials

Medicare details structure of new drug price negotiation program

Acelyrin, a rare IPO success, stumbles in its first big test

knowledge

Hospitals consider fixing cancer drug shortages on their own

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

NIH trials fail to test meaningful long Covid therapies, experts say

Police still searching for prisoner who escaped from NYC hospital

How housing is health care on Long Island

hotspot

focus

hotspot

entertainment